358 related articles for article (PubMed ID: 2245691)
41. The comparison of myocardial dysfunction in three forms of experimental septic shock.
Peevy KJ; Reed T; Chartrand SA; Olson RD; Boerth RC
Pediatr Res; 1986 Dec; 20(12):1240-2. PubMed ID: 3540827
[TBL] [Abstract][Full Text] [Related]
42. Antibiotics versus cardiovascular support in a canine model of human septic shock.
Natanson C; Danner RL; Reilly JM; Doerfler ML; Hoffman WD; Akin GL; Hosseini JM; Banks SM; Elin RJ; MacVittie TJ
Am J Physiol; 1990 Nov; 259(5 Pt 2):H1440-7. PubMed ID: 2240243
[TBL] [Abstract][Full Text] [Related]
43. The pathophysiology of septic shock: changes in hemodynamics in rats following live E coli injection. An application of the thermodilution method for measurement of cardiac output.
Sato T; Isoyama T; Tanaka J; Jones RT; Cowley RA; Trump BF
Adv Shock Res; 1982; 7():25-42. PubMed ID: 6753536
[TBL] [Abstract][Full Text] [Related]
44. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
[TBL] [Abstract][Full Text] [Related]
45. Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.
Garcia C; Saladino R; Thompson C; Hammer B; Parsonnet J; Wainwright N; Novitsky T; Fleisher GR; Siber G
Crit Care Med; 1994 Aug; 22(8):1211-8. PubMed ID: 8045139
[TBL] [Abstract][Full Text] [Related]
46. Reversal of myocardial dysfunction in endotoxin shock with insulin.
Archer LT; Beller BK; Drake JK; Whitsett TL; Hinshaw LB
Can J Physiol Pharmacol; 1978 Feb; 56(1):132-8. PubMed ID: 346182
[TBL] [Abstract][Full Text] [Related]
47. A controlled trial of HA-1A in a canine model of gram-negative septic shock.
Quezado ZM; Natanson C; Alling DW; Banks SM; Koev CA; Elin RJ; Hosseini JM; Bacher JD; Danner RL; Hoffman WD
JAMA; 1993 May; 269(17):2221-7. PubMed ID: 8474201
[TBL] [Abstract][Full Text] [Related]
48. Lack of defective cardiac oxidative metabolism in intact dogs subjected to a prolonged low-dose infusion of Escherichia coli endotoxin.
D'Orio V; el Allaf D; Vaira S; Fossion A; Juchmes J; Marcelle R
Circ Shock; 1986; 18(1):43-52. PubMed ID: 3080258
[TBL] [Abstract][Full Text] [Related]
49. Repeated plasma therapy induces fatal shock in experimental septicemia.
Busund R; Lindsetmo RO; Balteskard L; Rekvig OP; Revhaug A
Circ Shock; 1993 Aug; 40(4):268-75. PubMed ID: 8375029
[TBL] [Abstract][Full Text] [Related]
50. Plasma proteolysis and circulating cells in relation to varying endotoxin concentrations in porcine endotoxemia.
Naess F; Roeise O; Pillgram-Larsen J; Ruud TE; Stadaas JO; Aasen AO
Circ Shock; 1989 Jun; 28(2):89-100. PubMed ID: 2661049
[TBL] [Abstract][Full Text] [Related]
51. Splanchnic and systemic hemodynamic responses to portal vein endotoxin after resuscitation from hemorrhagic shock.
Gavin TJ; Fabian TC; Wilson JD; Trenthem LL; Pritchard FE; Croce MA; Stewart RM; Proctor KG
Surgery; 1994 Mar; 115(3):310-24. PubMed ID: 8128356
[TBL] [Abstract][Full Text] [Related]
52. Effects of plasma administration on gram negative shock in granulocytopenic dogs.
Crowley JP; Metzger J; Pivacek L; Dennis RC; Valeri CR
Circ Shock; 1988 Nov; 26(3):287-95. PubMed ID: 3061684
[TBL] [Abstract][Full Text] [Related]
53. Escherichia coli endotoxin depresses left ventricular contractility in neonatal lambs.
Sosa G; Milstein JM; Bennett SH
Pediatr Res; 1994 Jan; 35(1):62-7. PubMed ID: 8134201
[TBL] [Abstract][Full Text] [Related]
54. Treatment of septic shock with a protease inhibitor in a canine model: a prospective, randomized, controlled trial.
Tani T; Aoki H; Yoshioka T; Lin KJ; Kodama M
Crit Care Med; 1993 Jun; 21(6):925-30. PubMed ID: 8389269
[TBL] [Abstract][Full Text] [Related]
55. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock.
Rogiers P; Zhang H; Pauwels D; Vincent JL
Crit Care Med; 2003 Apr; 31(4):1219-25. PubMed ID: 12682496
[TBL] [Abstract][Full Text] [Related]
56. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals.
Fissell WH; Lou L; Abrishami S; Buffington DA; Humes HD
J Am Soc Nephrol; 2003 Feb; 14(2):454-61. PubMed ID: 12538747
[TBL] [Abstract][Full Text] [Related]
57. Gram negative septic shock. Experimental and clinical studies.
Motsay GJ
Int Surg; 1970 Aug; 54(2):81-92. PubMed ID: 4316996
[No Abstract] [Full Text] [Related]
58. A comparison of the cardiovascular, renal, and coronary effects of dopamine and monensin in endotoxic shock.
Somani P; Saini RK
Circ Shock; 1981; 8(4):451-64. PubMed ID: 7023738
[TBL] [Abstract][Full Text] [Related]
59. Escherichia coli sepsis and endotoxemia in conscious young pigs.
Schrauwen E; Cox E; Houvenaghel A
Vet Res Commun; 1988; 12(4-5):295-303. PubMed ID: 3057723
[TBL] [Abstract][Full Text] [Related]
60. Humoral factors in primate endotoxin shock.
May M; Pohlson EC; Siri F; McNamara JJ
Circ Shock; 1987; 22(2):127-39. PubMed ID: 3297377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
